 Basking Ridge, NJ, June 03, 2021 GLOBE NEWSWIRE -- via NewMediaWire -- Timber Pharmaceuticals, Inc. Timber or the Company NYSE American: TMBR, a biopharmaceutical company focused on the development and commercialization of treatments for rare and orphan dermatologic diseases, today announced that on June 3, 2021 its 2021 Annual Meeting of Stockholders the Annual Meeting was convened without a quorum. As a result, in order to provide stockholders additional time within which to vote their eligible shares to establish a quorum, the Annual Meeting was adjourned. 